A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
Authors:
- David BlumDBDavid Blum
- Catherine LedentCLCatherine Ledent
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 41 (2) , 570-576
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Adenosine as a neuromodulator in neurological diseasesCurrent Opinion in Pharmacology, 2008
- Minocycline in phenotypic models of Huntington's diseaseNeurobiology of Disease, 2004
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, RespectivelyJournal of Neuroscience, 2003
- A Dual Role of Adenosine A2AReceptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2AAntagonistsJournal of Neuroscience, 2003
- Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeuticsThe Lancet Neurology, 2003
- Striatal and Cortical Neurochemical Changes Induced by Chronic Metabolic Compromise in the 3-Nitropropionic Model of Huntington's DiseaseNeurobiology of Disease, 2002
- Replicating Huntington's disease phenotype in experimental animalsProgress in Neurobiology, 1999
- Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's diseasePhilosophical Transactions of the Royal Society B: Biological Sciences, 1999
- Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's diseaseAnnals of Neurology, 1992